Leishmania infections are able to inhibit CD40-induced N-Ras activation as a survival strategy switching CD40 signalling leading to inhibition of the p38MAPK pathway, the master regulator of transcript stability and tumour progression (Chakraborty et al., 2015; Soni et al., 2019). The gene discussed is CD40; the disease is neoplasm.